
Presentation of the report
This report has been prepared in accordance with the Norwegian Transparency Act (the “Transparency Act”) section 5 and summarizes the policies and procedures in Nattopharma AS (“Nattopharma”) with respect to safeguarding of human rights and decent working conditions and provides information on the imolementation and results of NattoPharma’s due diligence.
View the 2023 Transparency Act Report
Latest news & videos

- Adonat®
- Digestion & Gut
- Mobility & Joint
- Feb 17, 2025
Adonat® Shines in Vitamin Retailer’s Top 10 Stories of 2024
Vitamin Retailer's annual roundup of the top stories of 2024 features a standout article...

- Lynside® Nutritional Yeasts
- News
- Quatrefolic®
- Feb 14, 2025
Selenium-Enriched Nutritional Yeast: A Powerful Ally for Male Fertility
Male fertility is crucial in helping couples conceive and grow their families. At the...

- MenaQ7®
- News
- Vitamin K2
- Feb 13, 2025
Celebrate Valentine’s with Love and Cardiovascular Care!
The More Vitamin K2, the Better Your Heart Health! New research associates low K status...